A polymorphism in the cystatin C gene is a novel risk factor for late-onset Alzheimer's disease

Neurology

Volumn 55, Issue 6, 2000, Pages 763-768

  Crawford, F C ^a   Freeman, M J ^a   Schinka, J A ^a   Abdullah, L I ^a   Gold, M ^d   Hartman, R ^b   Krivian, K ^a   Morris, M D ^a   Richards, D ^a   Duara, R ^c   Anand, R ^b   Mullan, M J ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c MOUNT SINAI MEDICAL CENTER   (United States)

^d BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; APOLIPOPROTEIN E; CYSTATIN C; CYSTEINE PROTEINASE INHIBITOR;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0034718576     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.55.6.763     Document Type: Article

References (43)

1. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium
2. Relative risk of Alzheimer disease and age-at-onset distributions Caucasians, and Hispanics in New York City
3. The prevalence of apoE-epsilon4 in Alzheimer's disease is age dependent
4. Apolipoprotein E and Alzheimer disease: Genotype-specific risks by age and sex
5. ApoE-4 and age at onset of Alzheimer's disease: The NIMH genetics initiative
6. The relationship between apolipoprotein E, dementia, and vascular illness
7. Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease
8. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease
9. APOE-epsilon 4 in patients with Alzheimer disease and vascular dementia
10. Apolipoprotein E in patients with dementia of the Alzheimer type and vascular dementia
11. Vascular factors and Alzheimer disease
12. Vascular risk factors in dementia
13. Coronary artery disease, hypertension, APOE, and cholesterol: A link to Alzheimer's disease?
14. Factors associated with vascular dementia in an elderly community population
15. Dietary fat intake and the risk of incident dementia in the Rotterdam Study
16. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study
17. Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation
18. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study
19. Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease the CERAD experience, Part XV
20. Immunoreactive A4 and gamma-trace peptide colocalization in amyloidotic arteriolar lesions in brains of patients with Alzheimer's disease
21. Microvascular degeneration in hereditary cystatin C amyloid angiopathy of the brain
22. Stroke in Icelandic patients with hereditary amyloid angiopathy is related to a mutation in the cystatin C gene, an inhibitor of cysteine proteases
23. Hereditary cystatin C (gamma-trace) amyloid angiopathy of the CNS causing cerebral hemorrhage
24. On the role of monocytes/macrophages in the pathogenesis of central nervous system lesions in hereditary cystatin C amyloid angiopathy
25. Intracellular accumulation of the amyloidogenic L68Q variant of human cystatin C in NIH/3T3 cells
26. Cellular processing of the amyloidogenic cystatin C variant of hereditary cerebral hemorrhage with amyloidosis, Icelandic type
27. Apolipoprotein E genotyping by one-stage PCR
28. An Ala/Thr variation in the coding region of the human cystatin C gene (CST3) detected as a SstII polymorphism
29. No genetic association between polymorphisms in the Tau gene and Alzheimer's disease in clinic or population based samples
30. Gender specific association of the angiotensin converting enzyme (ACE) gene with Alzheimer's Disease
31. Aging and the occurrence of dementia: Findings from a population-based cohort with a large sample of nonagenarians
32. Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population
33. Alpha-2 macroglobulin is genetically associated with Alzheimer disease
34. Genetic association of the very low density lipoprotein (VLDL) receptor gene with sporadic Alzheimer's disease
35. Variation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease
36. APOE* 4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism
37. Association between Alzheimer's disease and the NOS3 gene
38. Synergy between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset confirmed Alzheimer's disease
39. Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland
40. The butyrylcholinesterase K variant and susceptibility to Alzheimer's disease
41. The butyrylcholinesterase gene is neither independently nor synergistically associated with late-onset AD in clinic- and community-based populations
42. The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage
43. Colocalization of beta/A4 and cystatin C in cortical blood vessels in Dutch, but not in Icelandic hereditary cerebral hemorrhage with amyloidosis